Navigation Links
New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy
Date:1/14/2009

>

Dr. Spatz's research is funded through the Robert Wood Johnson Clinical Scholars Program.

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.


'/>"/>
SOURCE American Heart Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NicOx Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis
2. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
3. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
4. New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity
5. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
6. Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
7. Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
8. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
9. Fralex provides update on timing of interim analysis results
10. Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
11. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... the District of New Jersey ... against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... that U.S. Patent No. 6,765,117 is both valid and ... its generic product until the expiration of that patent ...
(Date:8/29/2014)... 2014 Diseases largely eradicated in ... returning. Measles was declared eliminated in 2000, yet the ... August 15—the highest incidence in 20 years. In July, ... whooping cough a problem of "epidemic proportions." ... dying from these preventable diseases—in part because some parents ...
(Date:8/29/2014)... Research and Markets has announced ... Market 2014-2018" report to their offering. ... that results in demyelination, axonal transection, and neurodegeneration. The ... by the immune system, which targets neurons within the ... disease in which the damage of the myelin sheath ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... 9, 2011 /PRNewswire-USNewswire/ – CoMeD – On Friday, May ... filed an amendment to regulate vaccines containing mercury in ... buy, sell, manufacture, deliver, import, administer or distribute any ... or inorganic mercury per milliliter for children younger than ...
... 2011 Kinex Pharmaceuticals, LLC announced today that Dr. Allen ... decided to step aside as CEO. Dr. ... from a start-up biotechnology company with only a technology platform ... pre-IND to phase 2 developments. The recent collaboration established with ...
Cached Medicine Technology:Florida Legislature Refuses to Limit Mercury in Vaccines 2Florida Legislature Refuses to Limit Mercury in Vaccines 3The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer 2The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer 3
(Date:8/29/2014)... Indosoft, Inc. , a leading provider of scalable ... most advanced contact center product, Q-Suite 5.7.7. This ... as updates to existing aspects of its popular ... presentation side has received an update with the incorporation ... This WYSIWYG editor allows admins to easily add advanced ...
(Date:8/29/2014)... Denver, Colorado (PRWEB) August 29, 2014 ... perfect body is never easy. , According to ... dreamed body might be simpler than imagined with the ... reveals that Shapeshifter Yoga can be an amazingly effective ... Yoga review indicates that this new program is really ...
(Date:8/29/2014)... 29, 2014 Daily Gossip reveals in its ... a new method of naturally curing this disease. , ... to a permanent cure in only one week. This is ... need to make huge sacrifices. , Moreover, with this ... the symptoms of sciatica in just 8 minutes. , ...
(Date:8/29/2014)... Los Angeles, CA (PRWEB) August 29, 2014 ... site that connects the industry’s most notable plastic ... recommended doctors that write about cutting edge techniques ... checked to ensure they contain the most reliable ... select the right cosmetic treatment.     , Cosmetic Town ...
(Date:8/29/2014)... August 29, 2014 The Department of ... final rule (file code CMS–0052–P) today allowing healthcare providers ... 2011 Edition Certified EHR Technology (CEHRT) or a combination ... (EPs) who have not been able to fully implement ... in 2014 can continue to use 2011 Edition CEHRT, ...
Breaking Medicine News(10 mins):Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Shapeshifter Yoga Review Reveals Kris Fondran's New Body Shaping and Fat Loss Program 2Health News:Stop Sciatica in 8 Minutes Review Exposes Steven Guo's Complete Sciatica Cure 2Health News:Cosmetic Town Is Now Connecting Patients with Qualified Cosmetic Specialists 2Health News:Quirk Healthcare Outlook on MU2 Delay Confirmation 2
... global food crisis that started in 2007, leading to ... are malnourished. The Institute of Medicine will convene ... implications of the food crisis on nutrition and health. ... crisis and escalating food prices on nutrition, country and ...
... , , VIRGINIA BEACH, Va., July 7 ... with Arthrex, Inc., has released the KinetiGraft Tendon, the ... new options for ligament and tendon reconstruction. , ... medicine physicians another alternative in repairing patient injuries. KinetiGraft ...
... July 7 Whole Foods Market (Nasdaq: ... announced a commitment to the Non-GMO Project - a ... breeders and consumers - to use the Non-GMO,s Product ... private label products. , , (Photo: ...
... WILTON, Conn., July 7 Startech Environmental Corp. (OTC BB: STHK), ... shareholders not to take any action with respect to the commencement ... Holdings LLC to purchase all of the outstanding shares of Startech ... board of directors today said that it will carefully review the ...
... Premier Research Group Limited, the international clinical research ... Data Capture Onsite 4.5.3, the enhanced version of Oracle,s ... of trial sponsors as well as investigative site personnel. ... tradition of Oracle Clinical data management as an early ...
... (FHC) (Nasdaq-CM: FHCO) today announced that Fortune has ... small companies in America. Fortune,s annual top-100 list rates ... their annualized revenue growth and their total return to investors. ... recognized the core strengths and growth potential of Female Health ...
Cached Medicine News:Health News:LifeNet Health Launches Sports Medicine Bio-Implants 2Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 2Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 3Health News:Whole Foods Market(R) Partners With Non-GMO Project to Label Company's Private Label Food Products Using New Third-Party Standard 4Health News:Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 2Health News:Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 3Health News:Premier Research Launches Oracle(R) Remote Data Capture Onsite 4.5.3 2Health News:Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies 2Health News:Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies 3Health News:Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies 4